US Regulatory Reads, February 2019: Combo Products, Hacking Risks And Klobuchar
Executive Summary
The top US regulatory and policy stories last month covered FDA guidance documents, cyber-risks and one presidential candidate who appears to be maintaining her support for the medtech sector.